Logo

American Heart Association

  11
  0


Final ID:

AHA’s Role in Driving Cardiovascular Technologic Innovation

  • Harrington, Robert  ( Weill Cornell Medicine , New York , New York , United States )
  • Antman, Elliott  ( BRIGHAM WOMENS HOSPITAL , Weston , Massachusetts , United States )
  • Warner, John  ( OSU Wexner Medical Center , Columbus , Ohio , United States )
  • Author Disclosures:
    Robert Harrington: DO have relevant financial relationships ; Researcher:CSL Behring:Active (exists now) ; Other (please indicate in the box next to the company name):Cytokinetics Board of Directors:Active (exists now) ; Advisor:Medscape:Active (exists now) ; Consultant:Basking Bio:Active (exists now) ; Consultant:Foresight Lab:Active (exists now) ; Consultant:Edwards Lifescience:Active (exists now) ; Consultant:Element Science:Active (exists now) ; Consultant:Bridge Bio:Active (exists now) ; Consultant:BMS:Past (completed) ; Consultant:Bitterroot Bio:Active (exists now) ; Consultant:Atropos:Active (exists now) ; Researcher:Janssen:Active (exists now) | Elliott Antman: DO have relevant financial relationships ; Researcher:Itamar MEdical:Past (completed) ; Employee:AHA:Active (exists now) | John Warner: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts on this topic:
More abstracts from these authors:
Cardiogenic shock: A Team-Based Approach to Discovery and Clinical Management

Morrow David, Antman Elliott, Parillo Joseph

Mentorship and Sponsorship

Wang Tracy, Harrington Robert

You have to be authorized to contact abstract author. Please, Login
Not Available